Botulinum Toxin for Axillary Hyperhidrosis: A Practitioner Overview

Excessive underarm sweating is one of the more socially disruptive concerns patients bring to clinic, and it is also one of the most consistently responsive to botulinum toxin type A. This overview sets out how axillary hyperhidrosis is classified, why toxin works for it, and what practitioners should weigh before offering the treatment. It is educational and not an injection protocol.

Understanding Hyperhidrosis

Sweating is a normal thermoregulatory function, but for some patients the eccrine glands become overactive well beyond what temperature or exertion would explain. Hyperhidrosis is generally classified in two ways:

• By distribution — generalised hyperhidrosis affects the whole body, while localised hyperhidrosis is confined to specific sites such as the palms, soles, or axillae.
• By cause — primary hyperhidrosis has no identifiable underlying disease and is typically localised; secondary hyperhidrosis is generalised and linked to an underlying medical condition, warranting referral rather than aesthetic treatment.

Primary axillary hyperhidrosis is the presentation most commonly seen in aesthetic and dermatology clinics, and it is the focus here.

Why Botulinum Toxin Works for Sweating

Botulinum toxin's cosmetic use relies on blocking acetylcholine release at the neuromuscular junction, but its effect on sweat glands works through a related mechanism: it blocks acetylcholine release at the sympathetic nerve endings that innervate eccrine glands. With that signalling interrupted, glandular secretion in the treated area is substantially reduced without disrupting the body's overall thermoregulation. The approach has been used for hyperhidrosis since the 1990s and remains one of the better-evidenced applications of the toxin outside dynamic wrinkle correction.

Patient Selection

As with any botulinum toxin treatment, assessment precedes the decision to treat. Commonly cited considerations include:

• Pregnancy and breastfeeding
• Known neuromuscular junction disorders
• Active skin infection, open wounds, or inflammatory skin conditions in the treatment area
• Hypersensitivity to any component of the product
• Recent or planned dermatological procedures in the same site

Because primary hyperhidrosis is a diagnosis of exclusion, patients with a sudden onset, asymmetric or generalised sweating, or associated systemic symptoms warrant medical assessment before an aesthetic pathway is considered.

Benefits Commonly Reported

• Established track record. The technique has been used clinically for decades, with a well-characterised safety profile in appropriately selected patients.
• Efficient in-clinic treatment. Sessions are typically brief and carried out without anaesthesia.
• Defined onset. Effects are generally noticeable within a few days, with the full effect apparent by around two weeks.
• Meaningful duration. Results commonly last six to eight months before gradually wearing off.
• Localised action. The effect is confined to the treated area, without affecting sweat production elsewhere.

Considerations and Limitations

• Finite duration means repeat treatment. Patients should understand from the outset that results are not permanent and that maintenance sessions are part of the plan.
• Antibody-related resistance. A small proportion of patients develop reduced responsiveness over time; this is uncommon but worth discussing where relevant.
• Pre-treatment assessment. Ruling out secondary hyperhidrosis and confirming suitability takes time and should not be skipped.
• Transient injection-site effects. Mild tenderness, swelling, or a brief tingling sensation at injection sites are commonly reported and typically resolve within a day; more persistent symptoms may indicate the product was administered too deeply or in excess and should prompt review.

Supply Considerations for Clinics

Consistent, well-tolerated treatment for a diffuse area like the axilla depends on using appropriately fine needles for both reconstitution and delivery, which helps limit discomfort and bruising across the multiple injection points the area typically requires. Clinics building out their toxin workflow should keep a reliable stock of fine-gauge needles suited to this kind of multi-point treatment on hand.

The Takeaway

Botulinum toxin remains one of the most consistently effective non-surgical options for primary axillary hyperhidrosis, with a well-documented mechanism and duration that most patients find worthwhile. The trade-offs — repeat treatment, the need for careful diagnosis, and occasional resistance — are manageable with good patient selection and clear expectation-setting from the outset.

For fine-gauge needles and related injection supplies suited to multi-point treatments, browse the needles and syringes range.